tiprankstipranks
Ko Yo Chemical (Group) Limited (HK:0827)
:0827
Hong Kong Market

Ko Yo Chemical (Group) Limited (0827) AI Stock Analysis

0 Followers

Top Page

HK:0827

Ko Yo Chemical (Group) Limited

(0827)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
HK$0.03
▲(0.00% Upside)
Action:ReiteratedDate:01/13/26
The score is weighed down mainly by weak financial performance (profitability deterioration, high leverage, and lack of cash generation). Technicals are supportive in the very near term (price above major DMAs with positive MACD) but are heavily overbought, while valuation remains unfavorable due to losses and no indicated dividend yield.
Positive Factors
Exchange listing / capital access
Being listed on the Hong Kong Exchange gives durable access to deeper capital markets and investor pools. That structural access increases options for refinancing, rights issues or secondary raises, supporting strategic flexibility over the next several months.
Negative Factors
Severe margin deterioration
Margins collapsing to near-zero gross and deeply negative net margins signal structural pricing pressure or cost escalation. This undermines the core profitability model, limiting ability to rebuild reserves and sustain operations without structural operational or commercial fixes.
Read all positive and negative factors
Positive Factors
Negative Factors
Exchange listing / capital access
Being listed on the Hong Kong Exchange gives durable access to deeper capital markets and investor pools. That structural access increases options for refinancing, rights issues or secondary raises, supporting strategic flexibility over the next several months.
Read all positive factors

Ko Yo Chemical (Group) Limited (0827) vs. iShares MSCI Hong Kong ETF (EWH)

Ko Yo Chemical (Group) Limited Business Overview & Revenue Model

Company Description
Ko Yo Chemical (Group) Limited, an investment holding company, engages in the research and development, manufacture, marketing, and distribution of chemical products and chemical fertilizers in China. Its products include bulk blended fertilizer, ...
How the Company Makes Money
Ko Yo Chemical generates revenue through the production and sale of its chemical products, with key revenue streams derived from the sale of fertilizers and specialty chemicals. The company capitalizes on its established presence in the agricultur...

Ko Yo Chemical (Group) Limited Financial Statement Overview

Summary
Financial statements indicate severe stress: revenue fell (-10.13% YoY), margins collapsed (gross margin 1.31%) with a deeply negative net margin (-19.44%), leverage is very high (debt-to-equity 4.06; equity ratio 6.44%), and free cash flow is 0 with operating cash flow also reported as 0—raising liquidity and solvency concerns.
Income Statement
35
Negative
Balance Sheet
25
Negative
Cash Flow
20
Very Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.27B2.60B2.90B3.21B3.07B2.11B
Gross Profit-77.09M34.18M316.20M793.27M813.18M34.21M
EBITDA-133.72M-36.64M306.48M813.12M695.48M147.50M
Net Income-561.52M-505.39M-152.34M201.56M379.24M-241.78M
Balance Sheet
Total Assets4.86B5.41B6.27B5.85B4.04B2.85B
Cash, Cash Equivalents and Short-Term Investments29.04M8.10M62.93M224.06M413.26M14.54M
Total Debt2.81B3.40B3.69B3.14B2.56B2.18B
Total Liabilities4.69B5.05B5.35B4.79B3.21B2.83B
Stockholders Equity220.94M403.22M908.10M1.06B822.07M16.98M
Cash Flow
Free Cash Flow-88.34M-111.57M5.69M-58.83M-228.16M-52.82M
Operating Cash Flow-3.55M-103.33M224.47M715.30M435.30M6.58M
Investing Cash Flow201.89M280.47M-718.51M-1.16B-650.26M-57.80M
Financing Cash Flow-222.68M-232.57M332.57M272.77M593.86M55.62M

Ko Yo Chemical (Group) Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.03
Price Trends
50DMA
0.05
Positive
100DMA
0.04
Positive
200DMA
0.03
Positive
Market Momentum
MACD
<0.01
Positive
RSI
47.94
Neutral
STOCH
48.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0827, the sentiment is Neutral. The current price of 0.03 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 47.94 is Neutral, neither overbought nor oversold. The STOCH value of 48.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0827.

Ko Yo Chemical (Group) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$4.09B7.746.29%6.70%-3.73%6.09%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
HK$1.19B18.522.55%3.52%-5.29%-32.47%
59
Neutral
HK$1.24B7.693.65%2.20%-8.51%-68.34%
52
Neutral
HK$6.02B8.077.70%9.20%213.87%
43
Neutral
HK$372.49M-0.19-179.93%-22.72%-212.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0827
Ko Yo Chemical (Group) Limited
0.05
0.02
76.67%
HK:0609
Tiande Chemical Holdings Limited
1.35
0.40
42.11%
HK:1702
Dongguang Chemical Ltd.
1.99
0.50
33.56%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
5.13
3.63
242.00%
HK:0746
Lee & Man Chemical Co. Ltd.
4.96
1.76
55.00%

Ko Yo Chemical (Group) Limited Corporate Events

Ko Yo Chemical Advances Debt Restructuring and Specialty Chemical Projects to Support Going Concern
Dec 31, 2025
Ko Yo Chemical (Group) Limited has provided an update on its going-concern status and related mitigation measures, highlighting ongoing efforts to manage its substantial bank debt through renewals, restructurings and repayments. The group has rene...
Ko Yo Chemical Discloses CEO Emoluments for 2017-2018
Dec 17, 2025
Ko Yo Chemical (Group) Limited has provided supplemental disclosure regarding the emoluments of its Chief Executive Officer, Mr. Li Ciping, for the financial years 2017 and 2018. The announcement details specific compensations, including salaries,...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026